©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3377-3380
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3377
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3377
Contributing to the prediction of prognosis for treated hepatocellular carcinoma: Imaging aspects that sculpt the future
Cristian Lindner, Department of Radiology, Faculty of Medicine, University of Concepcion, Concepcion 4030000, Biobío, Chile
Cristian Lindner, Department of Radiology, Hospital Regional Guillermo Grant Benavente, Concepcion 4030000, Biobío, Chile
Author contributions: Lindner C wrote this article.
Conflict-of-interest statement: The author declares that there is no conflict of interest.
Corresponding author: Cristian Lindner, MD, Doctor, Department of Radiology, Faculty of Medicine, University of Concepcion, No. 1290 Victor Lamas, Concepcion 4030000, Biobío, Chile. clindner@udec.cl
Received: July 27, 2024
Revised: August 19, 2024
Accepted: August 28, 2024
Published online: October 27, 2024
Processing time: 63 Days and 0.2 Hours
Revised: August 19, 2024
Accepted: August 28, 2024
Published online: October 27, 2024
Processing time: 63 Days and 0.2 Hours
Core Tip
Core Tip: Emerging imaging techniques, particularly multiparametric magnetic resonance imaging and radiomics, enhance prognostic models for hepatocellular carcinoma (HCC) treated with radiofrequency ablation and transarterial chemoembolization. Incorporating advanced imaging features alongside clinical factors refines prediction accuracy, aiding personalized treatment and improving patient outcomes. This integration is crucial for advancing HCC prognosis and therapy.
